Olaparib (Lynparza) has now been approved by NICE as a second-line treatment of HER2-negative locally advanced or metastatic breast cancer in adults with mutated BRCA1 or BRCA2 genes who have had chemotherapy. Olaparib is a
In 2024 thanks to donors and fundraisers Secondary1st funded the first year of a research project led by Professor Simak Ali at Imperial College London investigating how changes in the ER gene contribute to hormone
The wonderful Alina, a specialist breast cancer nurse, arranged a pre-Christmas afternoon of music and song by courtesy of the Wellington Hospital. Three brilliant stars of musical theatre sang favourite songs from popular shows with
Next month the NHS will start to use a new ”ping and book” service to remind women via their phones that they are due or even overdue an appointment for breast cancer screening which they
Laurence has just walked over 350km to reach the halfway point of the Camino de Santiago in north-western Spain and has raised over £1000 for Secondary First …. and she is not finished yet!
In May
Seren is a drama therapist with a great deal of experience in helping people tackle their worries about chronic illness through creativity. She was diagnosed with secondary breast cancer and decided that something needed to
We recently marked our 8th anniversary. Since our launch in 2016 we have raised more than £890,000 and, thanks to our wonderful volunteers, 95% of the money raised goes to fund research. We have already
Professor Klaus Pors and his PhD student Enrica have been working for three years on a project to improve an extremely toxic chemotherapy, so that it can be used to treat breast cancer. The researchers
Kayleigh’s wonderful friend Brenna ran the London Marathon to raise funds for Secondary1st in memory of Kayleigh’s amazing Mum Kerry. Brenna was a true star and finished in the fantastic time of 3 hours 50
Secondary1st is proud to have been able to fund this research project led by Seth Coffelt, Professor of Cancer Immunology at Glasgow University. This report on the project is very detailed but we believe that